CD38 and chronic myelogenous leukemia, BCR-ABL1 positive: After this step, primary CML cells from newly diagnosed patients were sorted based on CD45dim/CD34+/CD38−/CD26− expression (HSCs) and CD45dim/CD34+/CD38−/CD26+ expression (CML LSCs) and were treated with IL-Rho.